● Recruiting

PRELUDE-1 (Prospective Evaluation of Radiotherapy-induced Biologic Effects in Colorectal Cancer Oligometastatic Patients with LUng-limited Disease: Evolution of Cancer Genetics and Regulatory Immune Cells)

Condition: Colorectal Cancer Metastatic · Sponsor: National Cancer Institute, Naples

PhaseNA

Planned participants25

Who can joinAll sexes, 18 Years to 80 Years

Healthy volunteersNo

About this study

PRELUDE-1 study is a pilot intervention trial that aims to describe the immunologic and genetic evolutions induced by stereotactic body radiationtherapy (SBRT) treatment in oligometastatic Colorectal Cancer (omCRC) patients with two-three nodules lung-limited disease.

This description comes directly from the study's public registry record.

Talk to the study team

Paolo Muto, MD · 0815903398 · p.muto@istitutotumori.na.it

Alessandro Ottaiano, MD · 0815903510 · a.ottaiano@istitutotumori.na.it

Always discuss trial participation with your own doctor first.

Locations (1)

Istituto Nazionale Tumori - Fondazione G. Pascale

Naples, NAPOLI, Italy

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04854213